Literature DB >> 20002622

Social adversity predicts ADHD-medication in school children--a national cohort study.

A Hjern1, G R Weitoft, F Lindblad.   

Abstract

AIMS: To test the hypothesis that psychosocial adversity in the family predicts medicated ADHD in school children.
METHOD: ADHD-medication during 2006 was identified in the Swedish Prescribed Drug Register in national birth cohorts of 1.1 million 6-19 year olds. Logistic regression models adjusted for parental psychiatric disorders were used to test our hypothesis.
RESULTS: There was a clear gradient for ADHD medication with level of maternal education, with an adjusted odds ratio of 2.20 (2.04-2.38) for the lowest compared with the highest level. Lone parenthood and reception of social welfare also implied higher risks of ADHD-medication with adjusted ORs of 1.45 (1.38-1.52) and 2.06 (1.92-2.21) respectively. Low maternal education predicted 33% of cases with medicated ADHD and single parenthood 14%.
CONCLUSIONS: Social adversity in the family predicts a considerable proportion of ADHD-medication in school children in Sweden.

Entities:  

Mesh:

Year:  2009        PMID: 20002622     DOI: 10.1111/j.1651-2227.2009.01638.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  38 in total

1.  Childhood Attention-Deficit/Hyperactivity Disorder Predicts Intimate Partner Victimization in Young Women.

Authors:  Maya D Guendelman; Shaikh Ahmad; Jocelyn I Meza; Elizabeth B Owens; Stephen P Hinshaw
Journal:  J Abnorm Child Psychol       Date:  2016-01

2.  Correspondence (letter to the editor): Uncritical prescription.

Authors:  Terje Neraal
Journal:  Dtsch Arztebl Int       Date:  2010-12-27       Impact factor: 5.594

3.  Characteristics of undiagnosed children with parent-reported ADHD behaviour.

Authors:  Kathrine Bang Madsen; Mette Holmelin Ravn; Jon Arnfred; Jørn Olsen; Charlotte Ulrikka Rask; Carsten Obel
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-21       Impact factor: 4.785

4.  Childhood attention problems and socioeconomic status in adulthood: 18-year follow-up.

Authors:  Cédric Galéra; Manuel-Pierre Bouvard; Emmanuel Lagarde; Grégory Michel; Evelyne Touchette; Eric Fombonne; Maria Melchior
Journal:  Br J Psychiatry       Date:  2012-05-24       Impact factor: 9.319

5.  Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study.

Authors:  Henrik Larsson; Amir Sariaslan; Niklas Långström; Brian D'Onofrio; Paul Lichtenstein
Journal:  J Child Psychol Psychiatry       Date:  2013-09-23       Impact factor: 8.982

6.  Demographic Characteristics and Psychiatric Comorbidity of Children and Adolescents Diagnosed with ADHD in Specialized Healthcare.

Authors:  Petteri Joelsson; Roshan Chudal; David Gyllenberg; Anna-Kaisa Kesti; Susanna Hinkka-Yli-Salomäki; Juha-Pekka Virtanen; Jukka Huttunen; Terja Ristkari; Kai Parkkola; Mika Gissler; Andre Sourander
Journal:  Child Psychiatry Hum Dev       Date:  2016-08

7.  Trajectories of childhood neighbourhood cohesion and adolescent mental health: evidence from a national Canadian cohort.

Authors:  M Kingsbury; J B Kirkbride; S E McMartin; M E Wickham; M Weeks; I Colman
Journal:  Psychol Med       Date:  2015-07-14       Impact factor: 7.723

8.  Prevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort Study.

Authors:  Ginny Russell; Lauren R Rodgers; Obioha C Ukoumunne; Tamsin Ford
Journal:  J Autism Dev Disord       Date:  2014-01

9.  Early psychosocial adversity and cortisol levels in children with attention-deficit/hyperactivity disorder.

Authors:  Johan Isaksson; Kent W Nilsson; Frank Lindblad
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02-09       Impact factor: 4.785

Review 10.  The Association Between Socioeconomic Disadvantage and Attention Deficit/Hyperactivity Disorder (ADHD): A Systematic Review.

Authors:  Abigail Emma Russell; Tamsin Ford; Rebecca Williams; Ginny Russell
Journal:  Child Psychiatry Hum Dev       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.